These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12953390)

  • 1. Under pressure.
    Siddall R
    Health Serv J; 2003 Aug; 113(5869):12-3. PubMed ID: 12953390
    [No Abstract]   [Full Text] [Related]  

  • 2. NBA/NBS perspective on nvCJD.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):329-30. PubMed ID: 10351146
    [No Abstract]   [Full Text] [Related]  

  • 3. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 4. Japan plans blood-donor restrictions to combat vCJD.
    Fuyuno I
    Nature; 2005 Mar; 434(7031):260. PubMed ID: 15772611
    [No Abstract]   [Full Text] [Related]  

  • 5. Universal leucodepletion--practical and regulatory consequences.
    Barrowcliffe TW
    Transfus Sci; 1998 Dec; 19(4):361. PubMed ID: 10351156
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products.
    Prowse C; Cuthbertson B; Turner M
    Haemophilia; 2011 Jul; 17(4):703. PubMed ID: 21362112
    [No Abstract]   [Full Text] [Related]  

  • 7. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 8. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 9. Implications of notifying donors and recipients.
    Hewitt PE
    Vox Sang; 2004 Jul; 87 Suppl 2():1-2. PubMed ID: 15209865
    [No Abstract]   [Full Text] [Related]  

  • 10. The sensibility of safety: reflections on the Krever inquiry's final report.
    Hoey J
    CMAJ; 1998 Jan; 158(1):59-60. PubMed ID: 9475910
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood groups differ on donor deferral.
    Mitka M
    JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment: dilemmas of dementia.
    Dodd RY
    J Clin Ethics; 2001; 12(2):141-2. PubMed ID: 11642065
    [No Abstract]   [Full Text] [Related]  

  • 13. United States considers ban on British blood.
    Gottlieb S
    West J Med; 1999 Aug; 171(2):132. PubMed ID: 10510663
    [No Abstract]   [Full Text] [Related]  

  • 14. Variant Creutzfeldt-Jakob disease (vCJD).
    Wkly Epidemiol Rec; 2001 Dec; 76(50):398-9. PubMed ID: 11797239
    [No Abstract]   [Full Text] [Related]  

  • 15. A commentary on variant Creutzfeld-Jacob disease.
    Hoots K
    Haemophilia; 2010 Mar; 16(2):238-9. PubMed ID: 20487441
    [No Abstract]   [Full Text] [Related]  

  • 16. Symposium on prions and transfusion safety.
    Coste J
    Transfus Clin Biol; 2013 Sep; 20(4):393-4. PubMed ID: 23928184
    [No Abstract]   [Full Text] [Related]  

  • 17. Removal of TSE agents from blood products.
    Foster PR
    Vox Sang; 2004 Jul; 87 Suppl 2():7-10. PubMed ID: 15209867
    [No Abstract]   [Full Text] [Related]  

  • 18. vCJD and blood transfusion in the United Kingdom.
    Hewitt P
    Transfus Clin Biol; 2006 Nov; 13(5):312-6. PubMed ID: 17188541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood supplies hit by vCJD fear.
    Strachan-Bennett S
    Nurs Times; 2004 Jan 6-12; 100(1):6. PubMed ID: 14735624
    [No Abstract]   [Full Text] [Related]  

  • 20. Logistical problems of supplying leucodepleted blood components within the national blood service.
    Tandy N
    Transfus Sci; 1998 Dec; 19(4):373-4. PubMed ID: 10351160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.